Central Nervous System Neoplasm research hub

Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia

This study looks at how well a medicine called larotrectinib works for children and young people with certain rare cancers that have a specific gene change (TRK fusion). It also checks for any side effects.